# Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

> **NCT07692841** · PHASE3 · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 560 (estimated)

## Conditions studied

- Healthy Hematopoietic Stem Cell Donor
- Healthy Allogeneic Hematopoietic Stem Cell Donor

## Interventions

- **DRUG:** Single-dose Granulocyte colony-stimulating factor (G-CSF)
- **DRUG:** Divided-dose Granulocyte colony-stimulating factor (G-CSF)

## Key facts

- **NCT ID:** NCT07692841
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2028-12-01
- **Final completion:** 2029-07-10
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2026-07-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692841, "Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*